UNSPSC 51282920: Garenoxacin

This classification denotes a quinolone antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V72H9867WB. European Medicines Agency schedules Garenoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25475. Garenoxacin generally arises in the molecular formula C23H20F2N2O4. The term GARENOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule garenoxacin under HS 29334990 and SITC 51575.

As of Q4 2014, GARENOXACIN remains the US FDA Preferred Term for this commodity. Garenoxacin bears US NLM identifiers UMLS ID C1507354 and NCI Concept Code C65800. SMILES: FC(F)OC1C2N(C3CC3)CC(C(=O)C2CCC1C1CC2C(C(NC2)C)CC1)C(=O)O.

UNSPSC 51282920 Garenoxacin is a Commodity code nominally for a single fluoroquinolone antibiotic, yet state and local procurement activity under this code shows substantial mismatch with the code's intended scope. Recent solicitations tagged to this code involve naloxone and drug deactivation systems, medical and first aid supplies for fire rescue, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer pharmacy programs—none of which are garenoxacin specifically. The code appears to function as a catch-all for pharmaceutical and medical supply procurements that state and local agencies classify inconsistently. When issuing bodies do buy under this code, they are sourcing emergency medical supplies, pharmacy benefit management services, and branded or generic drug inventory rather than a discrete pharmaceutical product. Issuing bodies include county health departments (Seminole County, Florida), city fire rescue divisions (Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Department of Administration).

Recent activity is concentrated in Florida, Texas, and Minnesota. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a due date of July 26, 2023 (note: the due date is inconsistent with the posting date and may reflect a data error in the source). The City of Tampa posted ITB 26P00145 in March 2026 for medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with a response deadline of March 13, 2026 and a 5 percent bid discount for certified Small Local Business Enterprises. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through the multistate MMCAP cooperative for generic multi-source pharmaceuticals and OTC products, with a proposal deadline of March 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs rather than issue a binding solicitation. The geographic spread and issuing-body diversity suggest the code captures fragmented demand across health departments, emergency services, and state procurement offices, with no dominant repeat buyer evident in recent postings.